BioPlus Specialty Pharmacy Now Dispensing New Prostate Cancer Medication Erleada™

08:00 EDT 17 Apr 2018 | PR Web

BioPlus Specialty Pharmacy, one of the nation’s leading innovative specialty pharmacies, can dispense the new FDA-approved limited distribution medication Erleada™ (apalutamide) for prostate cancer.

Altamonte Springs, FL (PRWEB) April 17, 2018

BioPlus Specialty Pharmacy (BioPlus), a leading innovative specialty pharmacy, is one of the specialty pharmacies granted access to the limited distribution medication Erleada™ (apalutamide) from Janssen Pharmaceuticals, Inc. BioPlus can help patients get started promptly with Erleada and support them throughout the treatment process.

Erleada is approved for the treatment of patients with prostate cancer that has not spread (non-metastatic), but continues to grow despite treatment with hormone therapy (castration-resistant). This oral medication earned FDA approval months ahead of the scheduled decision date and is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer. The FDA’s fast approval turnaround of Erleada was based on clinical trials of this medication showing a 72% reduction in risk of metastasis or death. Erleada is only available through a limited distribution network of specialty pharmacies, which includes BioPlus.

“We are excited to partner with Janssen in order to support men being treated with this new medication for prostate cancer; we offer extensive experience supporting oncology patients, as well as expertise from numerous prior limited distribution drug relationships,” shares Sharon Ferrer, VP of Pharmaceutical Relations at BioPlus. “Fast treatment starts are especially important when it comes to cancer treatment, which BioPlus helps makes possible with our 2-Day Ready to Ship program,” she adds.

For men, prostate cancer remains the second most common type of cancer (only skin cancer is diagnosed more often). Over the course of his lifetime, one in every seven men will develop prostate cancer and one in 39 men will die of prostate cancer.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 29 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, multiple sclerosis, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: or
Phone: 1-888-292-0744

For the original version on PRWeb visit:


More From BioPortfolio on "BioPlus Specialty Pharmacy Now Dispensing New Prostate Cancer Medication Erleada™"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...